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Impact of smoke-free legislation 
on perinatal and infant mortality: 
a national quasi-experimental 
study
Jasper V Been1-4, Daniel F Mackay5, Christopher Millett6, Jill P Pell5, Onno CP van Schayck2,3 
& Aziz Sheikh2,3,7,8
Smoke-free legislation is associated with improved early-life outcomes; however its impact on 
perinatal survival is unclear. We linked individual-level data with death certificates for all registered 
singletons births in England (1995–2011). We used interrupted time series logistic regression analysis 
to study changes in key adverse perinatal events following the July 2007 national, comprehensive 
smoke-free legislation. We studied 52,163 stillbirths and 10,238,950 live-births. Smoke-free legislation 
was associated with an immediate 7.8% (95%CI 3.5–11.8; p < 0.001) reduction in stillbirth, a 3.9% 
(95%CI 2.6–5.1; p < 0.001) reduction in low birth weight, and a 7.6% (95%CI 3.4–11.7; p = 0.001) 
reduction in neonatal mortality. No significant impact on SIDS was observed. Using a counterfactual 
scenario, we estimated that in the first four years following smoke-free legislation, 991 stillbirths, 
5,470 cases of low birth weight, and 430 neonatal deaths were prevented. In conclusion, smoke-free 
legislation in England was associated with clinically important reductions in severe adverse perinatal 
outcomes.
Fifty years after the official recognition of its adverse health effects, tobacco smoking remains the primary 
cause of preventable mortality worldwide1. Besides affecting smokers’ health, exposure to second-hand 
smoke (SHS) is estimated to cause over 600,000 deaths annually worldwide2. Children account for over a 
quarter of these deaths and over half of the estimated 10.9 million disability-adjusted life years (DALYs) 
attributable to SHS exposure2. Among the key adverse outcomes associated with early-life SHS exposure 
are low birth weight (birth weight < 2,500 grams)1,3, stillbirth1,4,5, and early-life mortality1, including sud-
den infant death syndrome (SIDS)1,6.
Population-level reductions in SHS exposure and active smoking can effectively be achieved by 
implementing legislation to prohibit smoking in enclosed public places and the workplace7. This 
is associated with significant health benefits among adults7,8. In a comprehensive assessment of its 
early-life health impact, we recently demonstrated that smoke-free legislation was associated with 
10% reductions in both preterm birth and hospitalisations for childhood asthma9. The improvements 
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in perinatal outcomes are likely mediated via reductions in maternal SHS exposure as well as active 
maternal smoking9–14. The data were however equivocal in relation to the impact on low birth weight 
babies9. We furthermore failed to identify any studies investigating the impact of smoke-free legisla-
tion on perinatal mortality, which was identified as a key knowledge gap9. Perinatal mortality is the 
primary contributor to the considerable global burden of under-five-mortality15. Given the urgent 
need for novel interventions in order to meet the fourth Millenium Development Goal of reduc-
ing this burden16, and the fact that only around 15% of the world’s population is currently covered 
by comprehensive smoke-free legislation17, the potential scope for improving early life outcomes is 
substantial.
We sought to address this by investigating the association between the 2007 national introduction 
of smoke-free legislation in England and various indicators of early-life mortality – namely stillbirth, 
neonatal mortality, and SIDS – in a national birth cohort of over 10 million singleton births. Given 
the conflicting evidence from previous studies9, we also evaluated the association between the legis-
lation and low birth weight and updated our meta-analysis using these data. We hypothesised that 
smoke-free legislation would be associated with a reduced risk of developing the adverse perinatal 
outcomes evaluated.
Results
Study population. During the study period, 10,291,113 singleton births were registered in England, 
including 52,163 stillbirths (0.5%; Fig. 1). Among the 10,238,950 singleton live-births, birth weight was 
recorded for 10,193,544 (99.6%), 606,800 (6.0%) of whom had low birth weight and 97,246 (1.0%) of 
whom had very low birth weight. Infant death occurred among 47,032 (0.5%) live-born infants and 
included 23,929 (0.2%) early neonatal deaths, 7,271 (0.1%) late neonatal deaths, and 15,832 (0.2%) 
post-neonatal deaths. 4,782 infant deaths were categorised as SIDS.
Stillbirth and early-life mortality were highly associated with low birth weight categories and low 
socioeconomic status, and less strongly with other demographic characteristics (Table 1). Important pre-
dictors of low birth weight included female sex, being a firstborn child, and low socioeconomic status 
(Table 2).
Smoke-free legislation and early-life outcomes. Introduction of smoke-free legislation was asso-
ciated with an immediate 7.8% (95% CI 3.5 to 11.8; p < 0.001) reduction in odds of being stillborn, a 
3.9% (95% CI 2.6 to 5.1; p < 0.001) reduction in odds of having low birth weight, and a 7.6% (95% CI 
3.4 to 11.7; p = 0.001) decrease in odds of neonatal mortality over-and-above the underlying temporal 
trend (Table 3 and Supplementary Table S1). No significant change in odds of SIDS was observed: 1.8% 
(95% CI − 8.4 to 13.2; p = 0.74).
The reduction in neonatal mortality was primarily attributable to an impact on late neonatal deaths: 
− 13.7% (95% CI − 20.7 to − 6.0; p = 0.001; Table 3 and Supplementary Table S2). A significant imme-
diate reduction in overall odds of infant mortality was also observed: − 6.3% (95% CI − 9.6 to − 2.9; 
p < 0.001). Smoke-free legislation was not associated with significant changes in the odds of the other 
secondary outcomes (Table 3).
Sensitivity analyses. The findings were highly robust in pre-specified (Table 3) and post-hoc sensi-
tivity analyses (Supplementary Table S3).
Figure 1. Flow diagram describing base population and number of individuals with primary and 
secondary outcomes .
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Live-births 
(n = 10,238,950)
Stillbirths 
(n = 52,163)
Infant deaths (n = 47,032)
All infant 
deaths 
(n = 47,032)
Neonatal deaths (n = 31,200)
Post-neonatal 
deaths 
(n = 15,832)
SIDS 
(4,782)
All neonatal 
deaths 
(n = 31,200)
Early neonatal 
deaths 
(n = 23,929)
Late neonatal 
deaths 
(n = 7,271)
Maternal age (years)
 <20 691,251 (6.8) 4,229 (8.1) 4,999 (10.6) 2,886 (9.3) 2,132 (8.9) 754 (10.4) 2,113 (13.3) 953 (19.9)
 20–24 1,926,659 (18.8) 10,007 (19.3) 10,356 (22.0) 6,457 (20.7) 4,884 (20.4) 1,573 (21.6) 3,899 (24.6) 1,465 (30.6)
 25–29 2,874,147 (28.1) 13,689 (26.2) 12,392 (26.3) 8,354 (26.8) 6,392 (26.7) 1,962 (27.0) 4,038 (25.5) 1,077 (22.5)
 30–34 2,954,400 (28.9) 13,668 (26.2) 11,225 (23.9) 7,848 (25.2) 6,131 (25.6) 1,717 (23.6) 3,377 (21.3) 793 (16.6)
 35–39 1,487,027 (14.5) 8,046 (15.4) 6,330 (13.5) 4,461 (14.3) 3,476 (14.5) 985 (13.5) 1,869 (11.8) 403 (8.4)
 ≥ 40 305,415 (3.0) 2,454 (4.7) 1,730 (3.7) 1,194 (3.8) 914 (3.8) 280 (3.9) 536 (3.4) 91 (1.9)
 Missing 51 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Parity
 0 2,441,463 (40.6) 10,849 (38.0) 10,353 (42.6) 7,637 (45.7) 5,950 (46.1) 1,687 (44.3) 2,716 (35.7) 386 (27.4)
 1 2,188,681 (36.4) 9,040 (31.6) 7,141 (29.4) 4,748 (28.4) 3,643 (28.3) 1,105 (29.0) 2,393 (31.4) 451 (32.0)
 2 884,312 (14.7) 4,630 (16.2) 3,712 (15.3) 2,349 (15.2) 1,788 (13.9) 561 (14.7) 1,363 (17.9) 302 (21.4)
 ≥ 3 496,592 (8.3) 4,053 (14.2) 3,102 (12.8) 1,960 (11.7) 1,507 (11.7) 453 (11.9) 1,142 (15.0) 270 (19.2)
 Missing 4,227,902 (41.3) 23,591 (45.2) 22,724 (48.3) 14,093 (46.5) 11,041 (46.1) 3,465 (47.7) 8,218 (51.9) 3,373 (70.5)
Marital status
 Married 6,011,122 (58.7) 28,573 (54.8) 24,308 (51.7) 16,694 (53.5) 12,888 (53.9) 3,806 (52.3) 7,614 (48.1) 1,409 (29.5)
 Not married 4,227,828 (41.3) 23,590 (45.2) 22,724 (48.3) 14,506 (46.5) 11,041 (46.1) 3,465 (47.7) 8,218 (51.9) 3,373 (70.5)
 Missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Sex
 Male 5,251,746 (51.3) 27,509 (52.7) 26,571 (56.5) 17,532 (56.3) 13,479 (56.3) 4,083 (56.2) 9,009 (56.9) 2,821 (59.0)
 Female 4,987,201 (48.7) 24,654 (47.3) 20,461 (43.5) 13,638 (43.7) 10,450 (43.7) 3,188 (43.8) 6,823 (43.1) 1,961 (41.0)
 Missing 3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Birth weight (grams)
 < 1000 41,737 (0.4) 15,719 (30.4) 16,073 (35.3) 13,826 (46.3) 11,496 (50.6) 2,330 (32.8) 2,247 (14.3) 66 (1.4)
 1000–1499 55,509 (0.5) 6,500 (12.6) 3,708 (8.1) 2,732 (9.2) 2,011 (8.8) 721 (10.2) 976 (6.2) 151 (3.2)
 1500–2499 509,554 (5.0) 11,722 (22.7) 7,175 (15.8) 4,202 (14.1) 3,055 (13.4) 1,147 (16.2) 2,973 (19.0) 869 (18.3)
 2500–3999 8,422,413 (82.6) 15,719 (30.4) 17,009 (37.4) 8,174 (27.4) 5,482 (24.1) 2,692 (37.9) 8,835 (56.4) 3442 (74.5)
 ≥ 4000 1,164,331 (11.4) 2,051 (4.0) 1,538 (3.4) 906 (3.0) 694 (3.1) 212 (3.0) 632 (4.0) 220 (4.6)
  Missing 45,406 (0.4) 453 (0.9) 1,529 (3.3) 1,360 (4.4) 1,191 (5.0) 169 (2.3) 169 (1.1) 34 (0.7)
IMD quintile
 1 (most deprived) 1,817,749 (18.2) 11,127 (21.7) 10,359 (22.6) 6,910 (22.8) 5,296 (22.8) 1,614 (22.6) 3,449 (22.2) 991 (21.4)
 2 2,618,898 (26.3) 14,467 (28.2) 13,546 (29.6) 8,980 (29.6) 6,895 (29.7) 2,085 (29.2) 4,566 (29.4) 1,253 (27.0)
 3 2,241,333 (22.5) 11,099 (21.6) 9,954 (21.7) 6,598 (21.7) 5,005 (21.6) 1,593 (22.3) 3,356 (21.6) 1,079 (23.3)
 4 1,953,029 (19.6) 8,984 (17.5) 7,536 (16.4) 4,892 (16.1) 3,737 (16.1) 1,155 (16.2) 2,644 (17.0) 816 (17.6)
 5 (least deprived) 1,344,295 (13.5) 5,664 (11.0) 4,466 (9.7) 2,960 (9.8) 2,264 (9.8) 696 (9.7) 1,506 (9.7) 497 (10.7)
 Missing 263,646 (2.6) 822 (1.6) 1,171 (2.5) 860 (2.8) 732 (3.1) 128 (1.8) 311 (2.0) 146 (3.1)
Region
 Greater London 1,891,740 (19.0) 11,258 (21.9) 9,163 (20.0) 6,046 (19.9) 4,551 (19.6) 1,495 (20.9) 3,117 (20.1) 716 (15.4)
  North East 471,619 (4.7) 2,458 (4.8) 2,102 (4.6) 1,347 (4.4) 998 (4.3) 349 (4.9) 755 (4.9) 277 (6.0)
 North West 1,355,390 (13.6) 7,131 (13.9) 6,907 (15.1) 4,439 (14.6) 3,360 (14.5) 1,079 (15.1) 2,468 (15.9) 879 (18.8)
 Yorkshire and the Humber 1,000,678 (10.0) 5,517 (10.7) 5,286 (11.5) 3,421 (11.3) 2,568 (11.1) 854 (12.0) 1,865 (12.0) 493 (10.6)
 East Midlands 726,852 (7.3) 3,615 (7.0) 3,354 (7.3) 2,316 (7.6) 1,775 (7.6) 531 (7.4) 1,074 (6.9) 348 (7.5)
 West Midlands 1,097,732 (11.0) 5,924 (11.5) 6,292 (13.7) 4,411 (14.5) 3,557 (15.3) 853 (11.9) 1,881 (12.1) 539 (11.6)
 East of England 1,026,552 (10.3) 4,670 (9.1) 3,819 (8.3) 2,494 (8.2) 1,931 (8.3) 563 (7.9) 1,325 (8.5) 364 (7.9)
 South East 812,769 (8.1) 3,508 (6.8) 2,650 (5.8) 1,724 (5.7) 1,317 (5.7) 407 (5.7) 926 (6.0) 326 (7.0)
 South Central 721,568 (7.2) 3,422 (6.7) 2,833 (6.2) 1,862 (6.1) 1,390 (6.0) 472 (6.6) 971 (6.3) 281 (6.1)
Continued
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Live-births 
(n = 10,238,950)
Stillbirths 
(n = 52,163)
Infant deaths (n = 47,032)
All infant 
deaths 
(n = 47,032)
Neonatal deaths (n = 31,200)
Post-neonatal 
deaths 
(n = 15,832)
SIDS 
(4,782)
All neonatal 
deaths 
(n = 31,200)
Early neonatal 
deaths 
(n = 23,929)
Late neonatal 
deaths 
(n = 7,271)
 South West 870,404 (8.7) 3,838 (7.5) 3,455 (7.5) 2,280 (7.5) 1,749 (7.7) 541 (7.6) 1,139 (7.3) 420 (9.1)
 Missing 263,646 (2.6) 822 (1.6) 1,171 (2.5) 860 (2.8) 732 (3.1) 128 (1.8) 311 (2.0) 146 (3.1)
Urbanisation level
 Urban 9,759,136 (97.8) 50,371 (98.1) 45,115 (98.4) 29,828 (98.3) 22,787 (98.2) 7,041 (98.6) 15,287 (98.5) 4,563 (98.4)
 Rural 216,168 (2.2) 970 (1.9) 746 (1.6) 512 (1.7) 410 (1.8) 102 (1.4) 234 (1.5) 73 (1.6)
 Missing 263,646 (2.6) 822 (1.6) 1,171 (2.5) 860 (2.8) 732 (3.1) 128 (1.8) 311 (2.0) 146 (3.1)
Table 1. Demographic characteristics according to mortality categories. Numbers represent numbers 
of babies in each stratum. Percentages in parentheses relate to all babies with valid data for that particular 
variable. For missing data, percentages of the full sample are given. SIDS = sudden infant death syndrome; 
IMD = Index of Multiple Deprivation.
Counterfactual estimates of cases averted. Using a counterfactual scenario (Figs  2 and 3), we 
estimated that in the first four years following the implementation of smoke-free legislation in England 
5,470 cases of low birth weight, 992 stillbirths, and 501 infant deaths, including 430 neonatal deaths, 
were averted.
Discussion
Introduction of smoke-free legislation in England was associated with clinically important reductions in 
stillbirth, low birth weight, and neonatal and infant mortality.
Analysing over 10 million births this is, to the best of our knowledge, one of the largest studies to 
have investigated the impact of smoke-free legislation on early life health, and the first to focus on peri-
natal mortality9. We obtained data from national birth and death registries, which constitute the primary 
source for the production of English national statistics, thereby minimising risks of individuals being 
missed. Registration of individual data items attained a high level of completeness, with over 97% of 
individuals having complete data on all covariates included in the primary analyses.
Our study has a number of potential limitations. We had no individual-level information on maternal 
smoking status during pregnancy. We were therefore unable to assess whether a possible reduction in 
maternal smoking following introduction of smoke-free legislation, as observed by others, contributed 
to the observed improvement in perinatal outcomes10–14. Also, a gestational age indicator was missing 
from the data, as this information was only recorded as an individual item by the Office for National 
Statistics from 2006 onwards. It was thus not possible to distinguish between the most common under-
lying causes of low birth weight: intrauterine growth restriction (i.e. being small for gestational age) and 
reduced length of gestation (i.e. being born preterm)18. In a recent meta-analysis, we demonstrated that 
smoke-free legislation was associated with reductions in the incidence of preterm birth and of being very 
small for gestational age9, suggesting that both mechanisms are likely to have contributed to the observed 
reduction in low birth weight identified. Similarly, we were unable to assess whether the decreases in neo-
natal and infant mortality identified may in part have been mediated via a reduction in preterm births9. It 
is however important to note that although missing data on gestational age and maternal smoking status 
limited the opportunity for a detailed assessment of possible causal pathways (Supplementary Figure S1), 
this had no bearing on the validity of our findings in relation to the main hypothesis under investigation.
When interpreting our findings it should be noted that over 50% of employed adults already worked 
in a smoke-free workplace before the legislation was implemented19. There is thus a risk that our study 
under-estimated the true potential impact of smoke-free legislation, which may be larger in countries 
with a lower proportion of smoke-free environments prior to implementation. In this respect, it is also 
important to note that this study was undertaken in a country with comparatively good early life out-
comes when judged against international standards20,21.
National public health interventions typically do not allow evaluation through randomised con-
trolled study designs22. We therefore evaluated the impact of smoke-free legislation by undertaking a 
quasi-experimental study, accepting consequential limitations in causal inference22. It is in such contexts 
important to consider other factors that may help inform causal reasoning. Particularly noteworthy is 
that the reductions in adverse early-life outcomes we identified are in line with previous studies demon-
strating particular perinatal health benefits as described above (i.e. reductions in low birth weight, 
being small for gestational age, and preterm birth)11–13,23–28. Furthermore, the link between smoke-free 
legislation and these reductions is highly plausible given that both SHS exposure and active smoking 
are well-established risk factors for adverse pregnancy outcomes and infant death1. Meta-analyses of 
studies among non-smoking women have shown that SHS exposure during pregnancy was associated 
www.nature.com/scientificreports/
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Birth weight ≥ 2,500 g 
(n = 9,586,744)
Low birth weight 
(n = 606,800)
Very low birth weight 
(n = 97,246)
Birth weight missing 
(n = 45,406)
Maternal age (years)
 < 20 632,058 (6.6) 56,372 (9.3) 8,999 (9.3) 2,821 (6.2)
 20–24 1,785,158 (18.6) 133,010 (21.9) 19,669 (20.2) 8,491 (18.7)
 25–29 2,697,989 (28.1) 163,814 (27.0) 25,485 (26.2) 12,344 (27.2)
 30–34 2,791,293 (29.1) 150,470 (24.8) 24,480 (25.2) 12,637 (27.9)
 35–39 1,397,224 (14.6) 82,428 (13.6) 14,705 (15.1) 7,375 (16.3)
 ≥ 40 283,019 (3.0) 20,706 (3.4) 3,908 (4.0) 1,691 (3.7)
 Missing 4 (0.0) 0 (0.0) 0 (0.0) 47 (0.1)
Parity
 0 2,271,216 (40.0) 156,788 (50.1) 24,541 (50.2) 13,495 (52.6)
 1 2,095,213 (36.9) 86,370 (27.6) 13,165 (26.9) 7,098 (27.7)
 2 841,217 (14.8) 40,002 (12.8) 6,282 (12.9) 3,093 (12.1)
 ≥ 3 465,144 (8.2) 29,492 (9.4) 4,875 (10.0) 1,956 (7.6)
 Missing 3,913,954 (40.8) 294,148 (48.5) 48,383 (49.8) 19,800 (43.6)
Marital status
 Married 5,672,849 (59.2) 312,659 (51.5) 48,865 (50.2) 25,614 (56.4)
 Not married 3,913,895 (40.8) 294,141 (48.5) 48,381 (49.8) 19,792 (43.6)
 Missing 0 (0.0) 0 (0.0) 0 (0.0) 0 (0)
Sex
 Male 4,939,679 (51.5) 288,753 (47.6) 49,784 (51.2) 23,314 (51.3)
 Female 4,647,062 (48.5) 318,047 (52.4) 47,462 (48.8) 22,092 (48.7)
 Missing 3 (0.0) 0 (0.0) 0 (0.0) 0 (0)
IMD quintile
 1 (most deprived) 1,676,895 (18.0) 129,769 (21.7) 21,871 (22.8) 11,085 (26.4)
 2 2,439,576 (26.1) 168,089 (28.0) 27,599 (28.8) 11,233 (26.8)
 3 2,100,475 (22.5) 132,485 (22.1) 21,227 (22.1) 8,373 (20.0)
 4 1,842,889 (19.7) 102,493 (17.1) 15,510 (16.1) 7,647 (18.2)
 5 (least deprived) 1,274,139 (13.7) 66,542 (11.0) 9,692 (10.1) 3,614 (8.6)
 Missing 252,770 (2.6) 7,422 (1.2) 1,347 (1.4) 3,454 (7.6)
Region
 Greater London 1,754,925 (18.8) 120,352 (20.1) 21,381 (22.3) 16,463 (39.2)
 North East 440,830 (4.7) 29,295 (4.9) 4,579 (4.8) 1,494 (3.6)
 North West 1,265,206 (13.6) 85,422 (14.3) 13,108 (13.7) 4,762 (11.4)
 Yorkshire and the Humber 932,580 (10.0) 64,903 (10.8) 9,851 (10.7) 3,195 (7.6)
 East Midlands 680,606 (7.3) 45,086 (7.5) 6,932 (7.2) 1,160 (2.8)
 West Midlands 1,020,237 (10.9) 75,470 (12.6) 12,132 (12.7) 2,025 (4.8)
 East of England 969,400 (10.4) 54,056 (9.0) 8,422 (8.8) 3,096 (7.4)
 South East 769,979 (8.2) 40,383 (6.7) 5,996 (6.3) 2,407 (5.7)
 South Central 680,340 (7.3) 38,901 (6.5) 6,345 (6.6) 2,327 (5.5)
 South West 819,871 (8.8) 45,510 (7.6) 7,153 (7.5) 5,023 (12.0)
 Missing 252,770 (2.6) 7,422 (1.2) 1,347 (1.4) 3,454 (7.6)
Urbanisation level
 Urban 9,128,455 (97.4) 589,290 (98.3) 94,414 (98.6) 41,391 (98.7)
 Rural 205,519 (2.6) 10,088 (1.7) 1,485 (1.4) 561 (1.3)
 Missing 252,770 (2.6) 7,422 (1.2) 1,347 (1.4) 3,454 (7.6)
Table 2. Demographic characteristics according to birth weight categories. Numbers represent numbers 
of live-born babies in each stratum. Percentages in parentheses relate to all babies with valid data for that 
particular variable. For missing data, percentages of the full sample are given. IMD = Index of Multiple 
Deprivation.
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Primary analysis
Sensitivity analyses
Model 1 Model 2
N OR 95%CI P-value N OR 95%CI P-value N OR 95%CI P-value
Primary outcomes
 Low birth weight 9,933,349 0.961 0.949–0.974 < 0.001 5,822,837 0.980 0.962–0.998 0.032 9,933,349 0.963 0.951–0.976 < 0.001
 Stillbirth 9,984,278 0.922 0.881–0.965 < 0.001 5,850,909 0.910 0.855–0.970 0.003 9,984,278 0.919 0.878–0.962 < 0.001
 Neonatal mortality 9,933,349 0.924 0.883–0.966 0.001 5,822,837 0.932 0.877–0.991 0.025 9,933,349 0.924 0.883–0.966 0.001
 SIDS 9,933,349 1.018 0.916–1.132 0.735 5,822,837 0.990 0.808–1.213 0.924 9,933,349 1.018 0.916–1.132 0.735
Secondary outcomes
 Very low birth weight 9,933,349 1.010 0.978–1.042 0.558
 Early neonatal mortality 9,933,349 0.958 0.890–1.032 0.258
 Late neonatal mortality 9,911,272 0.863 0.793–0.940 0.001
 Post-neonatal mortality 9,904,292 0.954 0.900–1.010 0.106
 Infant mortality 9,933,349 0.937 0.904–0.971 < 0.001
Table 3. Impact of smoke-free legislation on primary and secondary outcomes. Odds ratios indicate 
odds of developing outcome in period after versus period before July 2007, when smoke-free legislation 
was introduced. Primary models are adjusted for non-linear underlying time trends (via B-splines), month, 
maternal age, maternal marital status, sex, socioeconomic status, region, and urbanisation level and based 
on individual-level analysis of complete cases. Mortality models are furthermore adjusted for birth weight. 
For sensitivity analyses, model 1 is the complete case model with additional adjustment for parity, whereas 
in model 2 missing data for parity are imputed. OR = odds ratio; CI = confidence interval; SIDS = sudden 
infant death syndrome.
with a 1.32 (95% CI 1.07 to 1.63; p = 0.02) times increased risk of low birth weight and a 1.23 (95% 
CI 1.09 to 1.38; p < 0.001) times increased risk of stillbirth3,4. Furthermore, a dose-dependent inverse 
relationship between maternal urinary cotinine levels (as a proxy for SHS exposure) and offspring birth 
weight has recently been described29. Contemporary studies assessing the impact of SHS exposure on 
neonatal mortality are however lacking4,30. As for active maternal smoking during pregnancy, a reduc-
tion in which is highly likely to be on the causal pathway between smoke-free legislation and improved 
perinatal outcomes (Supplementary Figure S1)1,10–14 there is a strong association with adverse preg-
nancy outcomes as demonstrated by studies reporting a 36–60% increased risk for stillbirth and a 
20% increased risk for neonatal mortality1,5. Observational and experimental studies have found that 
maternal smoking cessation normalises these risks1,31–33. For example, a randomised controlled trial of 
a counselling intervention that successfully reduced SHS exposure during pregnancy reported a signifi-
cant improvement in birth outcomes34. We are unaware of other public health interventions or changes 
in perinatal practice co-occurring with the implementation of smoke-free legislation in England that 
may have been responsible for such substantial immediate reductions in several key adverse perinatal 
outcomes.
Although no previous studies have investigated the impact of smoke-free legislation on perinatal mor-
tality, several have studied its effect on birth weight11–13,23–26,35. In a recent meta-analysis of six studies, 
no significant overall impact on low birth weight could be demonstrated: − 1.7% (95% CI − 5.1 to 1.6; 
p = 0.31)9. We identified no new eligible studies in an update of this systematic review and meta-analysis 
(Supplementary Figure S2), focusing on (very) low birth weight and early-life mortality and following 
the methods described earlier36 Adding data from the current study to the existing meta-analyses, the 
overall reductions in the risk of low birth weight (7 studies, > 12.1 million subjects: − 2.20% [95% CI 
− 4.95 to 0.54], p = 0.115) and very low birth weight (3 studies, > 10.2 million subjects: − 2.61% [95% 
CI − 12.15 to 6.95], p = 0.591) following introduction of smoke-free legislation were not statistically 
significant. Of note however, the two studies that demonstrated a significant reduction in low birth 
weight were performed in countries where smoke-free legislation has been particularly comprehensive 
and compliance high12. Meta-analyses of smoke-free legislation and adult health have consistently shown 
that its health impact is larger when legislation is more comprehensive8,37. Additional studies are needed 
to study whether the same accounts for perinatal outcomes, which could further strengthen the case for 
WHO recommendations to implement comprehensive smoke-free laws17.
The association between smoke-free legislation and mortality was primarily attributable to a reduction 
in late neonatal mortality, which likely relates to the recognised association between antenatal smoke 
exposure and common causes of death in the late neonatal period38 such as necrotising enterocolitis39, 
bronchopulmonary dysplasia40,41, and sepsis42. We were unable to assess the differential association 
between smoke-free legislation and specific causes of death (except for SIDS) as this information was 
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Figure 2. Actual and counterfactual rates for primary outcomes. Actual rates are based on all registered 
singleton births in England for stillbirth (n = 10,291,113) and all singleton live-births for the other outcomes 
(n = 10,238,950). Counterfactual rates are model-predicted rates based on a complete case scenario but 
without impact of smoke-free legislation (n = 9,984,278 for stillbirth, n = 9,933,349 for other outcomes). 
Only outcomes where smoke-free legislation had a significant impact are shown. A: low birth weight; B: 
stillbirth; C: neonatal mortality. Models are adjusted for non-linear underlying time trends, seasonality, 
maternal age, maternal marital status, sex, socioeconomic status, region, and urbanisation level and based on 
complete cases. Mortality models are also adjusted for birth weight. Dotted line represents introduction of 
smoke-free legislation. Note different scales on Y-axis.
lacking from our data. Post-hoc sensitivity analyses indicate that the reduction in early-life mortality 
following smoke-free legislation was likely related to mechanisms other than improvement (i.e. increase) 
in birth weight.
Whereas we identified an overall association between smoke-free legislation and reduced infant mor-
tality, we were surprised by the finding that SIDS was not affected1,5. Boldo et al. previously estimated 
that SHS exposure was responsible for 310–420 SIDS cases annually in Europe, amounting to 1.6 excess 
cases per 100,000 in 20056. It is possible that our study lacked power to detect small changes in this rare 
outcome although the point estimate was not suggestive of possible benefit (Table 3). As SIDS is a diagno-
sis per exclusionem, temporal changes in the diagnostic approach towards unexplained infant death (e.g. 
changes in the proportion of explained deaths, changes in post-mortem examination rates, inter-observer 
variation in diagnostic criteria) may have resulted in unexplained variation43,44. Misclassification of SIDS 
may furthermore have influenced the data45. Of note, a recent multi-country ecological analysis found 
that higher tobacco taxes, but not smoke-free laws, were associated with significant reductions in SIDS 
rates46.
The impact of smoke-free legislation on perinatal and early-life health is likely to have been mediated 
via several routes. A number of previous studies have demonstrated important drops in maternal smok-
ing during pregnancy following implementation of smoke-free legislation1,10–14. In Scotland, for example, 
maternal smoking during pregnancy dropped from 25.4% to 18.8%12. At the same time, similar reductions 
in low birth weight were identified among women who smoked and those who did not smoke during 
pregnancy12, suggesting that at least part of the effect is mediated via mechanisms other than reducing 
active maternal smoking. Improvements in perinatal outcomes were observed among Norwegian moth-
ers whose workplace became smoke-free13. In Belgium, both the smoking ban in pubs and restaurants, 
as well as the workplace ban benefitted perinatal health23. Smoke-free legislation has furthermore been 
associated with important drops in smoking in the home through social norm spreading47–50. The impact 
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observed in our study is therefore likely to result from a mixture of reduced active smoking and reduced 
SHS exposure in the workplace, public places, and the home environment.
Our findings add an important new dimension to the emerging evidence on the benefits of smoke-free 
legislation to child health9,51, adding to the already well-established broad range of health benefits among 
adults7,8. Smoke-free laws are an inexpensive and efficient means to achieve sizeable improvements in 
population health52. Such laws are supported by the public, with support increasing further (particu-
larly amongst smokers) following implementation53. Considering that only around 15% of the world’s 
population is currently protected by comprehensive smoke-free laws17, and that low birth weight and 
perinatal mortality remain the primary causes of childhood morbidity and mortality worldwide18,21,54, 
accelerated action to implement smoke-free legislation is likely to help save considerable numbers of 
young lives across the globe and through doing so enhance the much-needed progress in meeting the 
fourth Millennium Development Goal.
Since the majority of the burden of early-life morbidity and mortality occurs in low- and middle-income 
countries18,21, there is a particular need for studies assessing the impact of smoke-free legislation in 
these regions9. Work is also needed to determine the impact of tobacco control policies on marginalised 
populations in high-income country settings, as variation in maternal smoking across socioeconomic 
subgroups has been shown to account for approximately one-third of the inequalities in stillbirths and 
infant deaths55. Finally, research also needs to investigate the differential early-life health impact of var-
ying degrees of comprehensiveness of smoke-free laws (e.g. extending the legislation to outdoor public 
places, private cars and homes) and different approaches to enforcement and success with compliance8.
In conclusion, we present evidence that implementation of smoke-free legislation in England was 
associated with substantial perinatal and early-life benefits, with over 5,000 cases of low birth weight and 
almost 1,500 deaths averted within four years.
Methods
This study was performed according to a pre-specified and registered research protocol (ClinicalTrials.
gov NCT02039583). Using a national dataset of all singleton births registered in England between 1995 
and 2011, we analysed the association between the July 2007 implementation of smoke-free legislation 
and the odds of stillbirth, low birth weight, and early-life mortality.
Ethical considerations. This study was reviewed by the National Health Services (NHS) South 
East Scotland Research Ethics Service and The University of Edinburgh’s Centre for Population Health 
Sciences Ethics Review Group. Both committees provided an exemption from formal ethical assessment 
based on the use of anonymised, unidentifiable data.
Figure 3. Actual and counterfactual rates for secondary outcomes. Actual rates are based on all registered 
live-births in England for infant mortality (n = 10,238,950) and on all babies alive at day seven after birth for 
late neonatal mortality (n = 10,207,750). Counterfactual rates are model-predicted rates based on a complete 
case scenario but without impact of smoke-free legislation (n = 9,911,272 for late neonatal mortality, 
n = 9,933,349 for infant mortality). Only outcomes where smoke-free legislation had a significant impact are 
shown. A: late neonatal mortality (n = 9,911,272); B: infant mortality (n = 9,933,349). Models are adjusted 
for non-linear time trends, month, maternal age, maternal marital status, sex, birth weight, socioeconomic 
status, region, and urbanisation level and based on complete cases. Dotted line represents introduction of 
smoke-free legislation. Note different scales on Y-axis.
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Implementation of smoke-free legislation. The intervention under study was the implementation 
of smoke-free legislation in England on 1 July 200756. From this date, smoking was prohibited in enclosed 
public places and workplaces in England, with very few exemptions (e.g. specialist tobacconist shops, 
designated rooms in palliative care hospices and in prisons). Immediate and sustained high levels of 
compliance with the smoke-free law have been attained, with over 98% of public premises and vehicles 
(e.g. taxis, private hire vehicles, coaches, and buses) found to be smoke-free in the first year following 
its implementation57.
Outcome definitions. Four primary outcomes were evaluated: low birth weight (live-birth with birth 
weight < 2,500 grams); stillbirth (intrauterine death from 24 weeks of gestation); neonatal death (death 
in the first 28 days of life); SIDS (death within the first year of life coded on the death certificate as 
International Classification of Diseases (ICD) 10-U R95, or R99 with no other specification).
In addition, we considered the following secondary outcomes: very low birth weight (live-birth with 
birth weight < 1,500 grams); early neonatal death (death in the first week of life); late neonatal death 
(death between 7 and 28 days of life); post-neonatal death (death between 28 days of life and the first 
birthday); and infant death (death within the first year of life).
Data on gestational age were not available through the Office for National Statistics before 2006, 
restricting the pre-legislation period to only 1.5 years. Given the recognised seasonal variation in gesta-
tional age we considered this period insufficient to estimate underlying trends pre-legislation, and there-
fore decided a priori not to involve preterm birth as an outcome or intermediate variable in our analyses.
Data sources and study population. Individual-level data on all registered singleton births in 
England between 1 January 1995 and 31 December 2011 were obtained via the government’s Office for 
National Statistics. Data were linked by the Office for National Statistics to death certificates for stillbirths 
and for all infants dying before their first birthday. To minimise the risks of individuals being identified, 
individual-level continuous variables were categorized as follows: month and year of birth; month and 
year of death; timing of death (stillbirth/early neonatal/late neonatal/post-neonatal); sex; birth weight 
(< 1,000 grams/1,000–1,499 grams/1,500–2,499 grams/2,500–3,999 grams/≥ 4,000 grams); maternal mar-
ital status (married /not married); maternal parity; and maternal age (< 20 years/20–24 years/25–29 
years/30–34 years/35–39 years/≥ 40 years). The individual-level data also included Government Office 
Region, urbanisation level (urban/rural, based on Office for National Statistics classification for small 
area geographies), and socioeconomic status measured using the Index of Multiple Deprivation (in quin-
tiles), these being derived from maternal post code of residence. The Index of Multiple Deprivation is a 
relative measure of deprivation at the small-area level58; an aggregate score is produced from 38 indica-
tors in seven domains, namely: income; employment; health; education; crime; access to services; and 
living environment58.
Statistical analyses. The patterning of demographic data was initially tabulated by timing of death 
and birth weight categories. Separate logistic regression models using individual-level data were then 
developed to investigate the association between the introduction of smoke-free legislation and the 
odds of developing each outcome12. Akaike’s and Schwarz’s Bayesian information criteria (AIC and BIC, 
respectively) were used to select the optimal model from among six options (Supplementary Figure S3): a 
linear time-trend model with a sudden (‘step’) change in the odds of developing the outcome at the time 
of introduction of smoke-free legislation; a linear time-trend model with a gradual (‘slope’) change in 
odds following the introduction of smoke-free legislation; a linear time-trend model with both a step and 
a slope change; and three models with a step change only and the underlying time trends being modelled 
via linear, quadratic, and cubic B-splines, respectively59. A continuous time variable based on month of 
birth was used for linear time trend models. Via addition of these temporal trend terms all models thus 
accounted for the pre-existing (i.e. before introduction of smoke-free legislation) underlying trend in the 
odds of developing each outcome. The step change was modeled using a dummy variable code ‘0’ before 
and ‘1’ after the introduction of smoke-free legislation19. An interaction term between this dummy and 
the continuous time variable was included to model a slope change51,60. In addition, a categorical variable 
for month was added to each model to account for any seasonality in the data51,60.
The following categorical covariates were included in each model to account for potential 
individual-level confounding: sex; maternal age; maternal marital status; Index of Multiple Deprivation 
quintile; region; and urbanisation level. All mortality-related outcomes were also adjusted for birth 
weight.
Among the model covariates, data on parity were missing for a substantial portion of the study popu-
lation (41.3%), as this variable had been recorded for married women only. All other covariates had 0–3% 
missing data. Since logistic regression analysis needs to be undertaken on cases with complete data for all 
covariates, parity was excluded from the primary models to maximise power. We performed two sets of 
pre-specified sensitivity analyses to investigate potential residual confounding resulting from exclusion of 
parity as a covariate. In the first set, models were re-run with parity included, analysing individuals with 
complete data only. In the second set, multiple imputations were performed using chained equations to 
impute missing data for parity, creating five unique datasets12. Models were then re-run on the imputed 
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data. Sensitivity analyses were conducted for the primary outcomes only to minimise risks associated 
with multiple testing.
A change in odds of developing low birth weight following the introduction of smoke-free legislation 
is potentially on the causal pathway between smoke-free legislation and any observed impact on early-life 
mortality (Supplementary Figure S1). We therefore performed additional post-hoc sensitivity analyses to 
test whether exclusion of birth weight as a covariate from the models had any impact on the observed 
association between smoke-free legislation and early-life mortality.
In order to estimate the absolute impact of smoke-free legislation for outcomes that were significantly 
affected, we developed counterfactual scenarios51,60. For each individual, a predicted risk of developing 
the outcome was calculated using the Betas from the primary models, but setting the ban dummy at ‘0’ 
for the entire study period. This counterfactual risk thus represented the theoretical risk of developing the 
outcome, had smoke-free legislation not been implemented. We then subtracted the actual risk from the 
counterfactual risk, producing an excess risk for each individual. These were summed for the first four 
full years following smoke-free legislation, producing an estimate of the total number of cases averted 
for each outcome.
All analyses were undertaken using Stata SE version 12.0 (Statacorp, TX).
Sample size considerations. As we used the maximum time span and population available, sample 
size calculations were redundant. Given the national nature of this evaluation, we estimated that we would 
have adequate power to detect clinically relevant temporal changes in the outcomes of interest9. A num-
ber of studies have previously assessed the impact of smoke-free legislation on low birth weight11–13,23–26. 
Our approach was comparable to that previously employed in Scotland12. Using data on 757,795 deliver-
ies occurring between 1996 and 2009, this work showed an immediate − 9.9% (95% CI − 14.2 to − 5.2; 
p < 0.001) drop in low birth weight babies12. Given the longer study period (1995–2011) and the much 
larger population size (n > 10 million), the current study was expected to have sufficient power to detect 
a similar reduction in low birth weight babies in England, if present. Earlier studies of the impact of 
smoke-free laws on SIDS are hampered by their ecological design and these were therefore not suitable 
to inform deliberations on power considerations for the current study27,46.
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